A new research effort takes aim at 8 rare diseases. It could revolutionize many more.

Published on 24 May 2023 on USA TODAY via Yahoo News

Terry Pirovolakis raised $4.5 million ‒ $20 at a time ‒ to help develop treatments for his son...

Read the rest of the article

Start tracking your investments with Statfolio

From what we can see, insiders were net buyers in Ovid Therapeutics Inc.'s (NASDAQ:OVID ) during ...

Simply Wall St. · via Yahoo Finance 23 Jan 2025

As the U.S. stock market experiences a downturn, with the S&P 500 on track to end its three-week ...

Simply Wall St. · via Yahoo Finance 13 Dec 2024

We recently compiled a list of the 10 Best Penny Stocks to Buy Under $1. In this article, we are ...

Insider Monkey · via Yahoo Finance 21 Jul 2024

Last week, Ovid Therapeutics Inc. (NASDAQ:OVID) insiders, who had purchased shares in the previou...

Simply Wall St. via Yahoo Finance 22 Mar 2024

Key Insights Significantly high institutional ownership implies Ovid Therapeutics' stock price is...

Simply Wall St. via Yahoo Finance 21 Jan 2024

OVID received a $30 million payment from Ligand for the sale of a 13% interest in the potential f...

GuruFocus.com via Yahoo Finance 6 Nov 2023

In this article, we will take a detailed look at the 20 countries with the highest rates of epile...

Insider Monkey via Yahoo Finance 30 Sep 2023

Madison Avenue Partners, LP (Trades, Portfolio), a New York-based investment firm, recently incre...

GuruFocus.com via Yahoo Finance 1 Aug 2023

Key Insights Institutions' substantial holdings in Ovid Therapeutics implies that they have signi...

Simply Wall St. via Yahoo Finance 2 Jul 2023

Terry Pirovolakis raised $4.5 million ‒ $20 at a time ‒ to help develop treatments for his son...

USA TODAY via Yahoo News 24 May 2023